Despite pharma’s best efforts to improve systems for calling on physicians, access to targets remains a problem across the industry.
Via Philippe Marchal
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
![]() ![]()
No comment yet.
Sign up to comment
rob halkes's curator insight,
November 8, 2013 5:40 AM
Great insight into the next age of health provision! Given the current economic and health budgets' condtions, but also raising demands on health quality, will bring different parties in care provision together. When they can find ways to integrate their business models, which is one of the hardest issues to complete, new cost savings might render sustainable return to the partners in care. Health industry and health care parties have a challenge ahead.
Want to know more? Just connet with me and find out about the various ways, I can inform you about my practical experiences to this.
rob halkes's curator insight,
November 8, 2013 5:48 AM
Great insight into the next age of health provision! Given the current economic and health budgets' condtions, but also raising demands on health quality, will bring different parties in care provision together. When they can find ways to integrate their business models, which is one of the hardest issues to complete, new cost savings might render sustainable return to the partners in care. Health industry and health care parties have a challenge ahead.
Want to know more? Just connet with me and find out about the various ways, I can inform you about my practical experiences to this.
Felix Jackson's curator insight,
September 20, 2013 5:21 AM
Specific considerations for social media: • “clear corporate social media policy and provide adequate training to employees.” • “if you plan to allow third-party content on company-hosted media, ensure [that] you maintain control to maintain compliance.” • Have a clear “terms of use” to alert users that content will be reviewed and may be deleted.
But the main considerations remain the big ones: • partner with marketing team members to ensure risk presentations get equal time and attention in promotional materials during the drafting stage (including labeling); • lean on medical reviewers to understand study designs and the limitations for supporting data; • not overlook investigational product materials and websites; • ensure product-related press releases undergo multidisciplinary review; and • inventory claims supported by composite score data for overstatement of efficacy.
Alex Butler's curator insight,
October 4, 2013 11:46 AM
How can healthcare and pharma be inspired by other industries? I they could be who would they take inspiration from to drive innovation? Could other industries be inspired by healthcare?
The pod are joined by special guest Angela Dunn (@blogbrevity) who lends her considerable expertise to the topic, joining the usual team line-up |
COM SALUD's curator insight,
December 17, 2013 3:37 AM
Aunque las restricciones en la comunicación con los pacientes no son las mismas en Estados Unidos que en Europa, se puede aprender mucho de la labor en redes sociales que muchos laboratorios realizan en otros países. No tratan de "vender" las ventajas de un medicamento sino de involucrar a los pacientes en aspectos como la prevención y el autocuidado de su salud, lo que éstos agradecen en las redes.
eMedToday's curator insight,
December 7, 2013 1:58 AM
-Capgemini Consulting, the global strategy and transformation consulting arm of the Capgemini Group, in collaboration with leading physician relationship management provider Quantia, today announced findings from a new joint study that shows pharmaceutical companies’ shrinking access to physicians through traditional sales representatives is putting their in-office engagement strategy in flux. The study of nearly 3,000 primary care physicians and specialists from the QuantiaMD U.S. community, found that 67 percent of physicians now rate digital media as their preferred source for accessing information, compared to just 20 percent who prefer pharmaceutical representatives. This shift is compelling pharmaceutical companies to place more emphasis on their digital strategies to maintain their role as a trusted information resource.
Estelle Ayer's curator insight,
December 9, 2013 3:26 AM
New role of pharmaceutical reps, evolution of working models thanks to digital
eMedToday's curator insight,
July 26, 2013 8:12 PM
This does reflect the changing trend. However, problem is getting in front of the doctor. Self directed e detialing it the future |